{"entity":{"type":"insider","cik":"0001618205","url":"/insider/0001618205","json_url":"/insider/0001618205.json","name":"Birchview Capital, LP","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":17,"n_filings":4,"first":"2015-06-23","last":"2024-02-20","span_basis":"filed_date"},"name_variants":[{"name":"Birchview Capital, LP","source":"filing","n_filings":4,"first_seen":"2015-06-23","last_seen":"2024-02-20"}],"transactions":[{"id":9223847,"accession":"0001104659-24-025392","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001104659-24-025392","line_url":"/filing/0001104659-24-025392#line-5","is_derivative":false,"issuer_cik":"0001377832","issuer_name":"ELUTIA INC.","issuer_ticker":"ELUT","issuer_name_source":null,"issuer_url":"/issuer/0001377832","owner_cik":null,"owner_name":"Birchview Capital, LP; Birchview Fund LLC; Strobeck Matthew","owner_url":null,"role":"Other","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.587,"price_display":"1.59","price_state":"stated","total_value":15870.0,"total_display":"15,870.00","shares_owned_after":1655184.0,"shares_owned_after_display":"1,655,184","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-27","filed_date":"2024-02-20","scope":"insider"},{"id":7891196,"accession":"0001104659-23-037129","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001104659-23-037129","line_url":"/filing/0001104659-23-037129#line-5","is_derivative":false,"issuer_cik":"0001377832","issuer_name":"AZIYO BIOLOGICS, INC.","issuer_ticker":"AZYO","issuer_name_source":null,"issuer_url":"/issuer/0001377832","owner_cik":null,"owner_name":"Birchview Fund LLC; Birchview Capital, LP; Strobeck Matthew","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.587,"price_display":"1.59","price_state":"stated","total_value":15870.0,"total_display":"15,870.00","shares_owned_after":1655184.0,"shares_owned_after_display":"1,655,184","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-27","filed_date":"2023-03-27","scope":"insider"},{"id":9223849,"accession":"0001104659-24-025392","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-24-025392","line_url":"/filing/0001104659-24-025392#line-3","is_derivative":false,"issuer_cik":"0001377832","issuer_name":"ELUTIA INC.","issuer_ticker":"ELUT","issuer_name_source":null,"issuer_url":"/issuer/0001377832","owner_cik":null,"owner_name":"Birchview Capital, LP; Birchview Fund LLC; Strobeck Matthew","owner_url":null,"role":"Other","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":18000.0,"shares_display":"18,000","price_per_share":1.3539,"price_display":"1.35","price_state":"stated","total_value":24370.2,"total_display":"24,370.20","shares_owned_after":1643184.0,"shares_owned_after_display":"1,643,184","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-24","filed_date":"2024-02-20","scope":"insider"},{"id":9223846,"accession":"0001104659-24-025392","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-24-025392","line_url":"/filing/0001104659-24-025392#line-4","is_derivative":false,"issuer_cik":"0001377832","issuer_name":"ELUTIA INC.","issuer_ticker":"ELUT","issuer_name_source":null,"issuer_url":"/issuer/0001377832","owner_cik":null,"owner_name":"Birchview Capital, LP; Birchview Fund LLC; Strobeck Matthew","owner_url":null,"role":"Other","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":1.3539,"price_display":"1.35","price_state":"stated","total_value":2707.8,"total_display":"2,707.80","shares_owned_after":1645184.0,"shares_owned_after_display":"1,645,184","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-24","filed_date":"2024-02-20","scope":"insider"},{"id":7891194,"accession":"0001104659-23-037129","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-23-037129","line_url":"/filing/0001104659-23-037129#line-4","is_derivative":false,"issuer_cik":"0001377832","issuer_name":"AZIYO BIOLOGICS, INC.","issuer_ticker":"AZYO","issuer_name_source":null,"issuer_url":"/issuer/0001377832","owner_cik":null,"owner_name":"Birchview Fund LLC; Birchview Capital, LP; Strobeck Matthew","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":18000.0,"shares_display":"18,000","price_per_share":1.3539,"price_display":"1.35","price_state":"stated","total_value":24370.2,"total_display":"24,370.20","shares_owned_after":1643184.0,"shares_owned_after_display":"1,643,184","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-24","filed_date":"2023-03-27","scope":"insider"},{"id":7891191,"accession":"0001104659-23-037129","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-23-037129","line_url":"/filing/0001104659-23-037129#line-3","is_derivative":false,"issuer_cik":"0001377832","issuer_name":"AZIYO BIOLOGICS, INC.","issuer_ticker":"AZYO","issuer_name_source":null,"issuer_url":"/issuer/0001377832","owner_cik":null,"owner_name":"Birchview Fund LLC; Birchview Capital, LP; Strobeck Matthew","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":1.3539,"price_display":"1.35","price_state":"stated","total_value":2707.8,"total_display":"2,707.80","shares_owned_after":1645184.0,"shares_owned_after_display":"1,645,184","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-24","filed_date":"2023-03-27","scope":"insider"},{"id":9223848,"accession":"0001104659-24-025392","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-025392","line_url":"/filing/0001104659-24-025392#line-1","is_derivative":false,"issuer_cik":"0001377832","issuer_name":"ELUTIA INC.","issuer_ticker":"ELUT","issuer_name_source":null,"issuer_url":"/issuer/0001377832","owner_cik":null,"owner_name":"Birchview Capital, LP; Birchview Fund LLC; Strobeck Matthew","owner_url":null,"role":"Other","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":1.491,"price_display":"1.49","price_state":"stated","total_value":149100.0,"total_display":"149,100.00","shares_owned_after":1615184.0,"shares_owned_after_display":"1,615,184","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-23","filed_date":"2024-02-20","scope":"insider"},{"id":9223845,"accession":"0001104659-24-025392","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-025392","line_url":"/filing/0001104659-24-025392#line-2","is_derivative":false,"issuer_cik":"0001377832","issuer_name":"ELUTIA INC.","issuer_ticker":"ELUT","issuer_name_source":null,"issuer_url":"/issuer/0001377832","owner_cik":null,"owner_name":"Birchview Capital, LP; Birchview Fund LLC; Strobeck Matthew","owner_url":null,"role":"Other","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.491,"price_display":"1.49","price_state":"stated","total_value":14910.0,"total_display":"14,910.00","shares_owned_after":1625184.0,"shares_owned_after_display":"1,625,184","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-23","filed_date":"2024-02-20","scope":"insider"},{"id":7891188,"accession":"0001104659-23-037129","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-037129","line_url":"/filing/0001104659-23-037129#line-2","is_derivative":false,"issuer_cik":"0001377832","issuer_name":"AZIYO BIOLOGICS, INC.","issuer_ticker":"AZYO","issuer_name_source":null,"issuer_url":"/issuer/0001377832","owner_cik":null,"owner_name":"Birchview Fund LLC; Birchview Capital, LP; Strobeck Matthew","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":1.491,"price_display":"1.49","price_state":"stated","total_value":149100.0,"total_display":"149,100.00","shares_owned_after":1615184.0,"shares_owned_after_display":"1,615,184","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-23","filed_date":"2023-03-27","scope":"insider"},{"id":7891186,"accession":"0001104659-23-037129","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-037129","line_url":"/filing/0001104659-23-037129#line-1","is_derivative":false,"issuer_cik":"0001377832","issuer_name":"AZIYO BIOLOGICS, INC.","issuer_ticker":"AZYO","issuer_name_source":null,"issuer_url":"/issuer/0001377832","owner_cik":null,"owner_name":"Birchview Fund LLC; Birchview Capital, LP; Strobeck Matthew","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.491,"price_display":"1.49","price_state":"stated","total_value":14910.0,"total_display":"14,910.00","shares_owned_after":1625184.0,"shares_owned_after_display":"1,625,184","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-23","filed_date":"2023-03-27","scope":"insider"},{"id":8118487,"accession":"0001104659-23-019991","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001104659-23-019991","line_url":"/filing/0001104659-23-019991#line-6","is_derivative":false,"issuer_cik":"0001377832","issuer_name":"AZIYO BIOLOGICS, INC.","issuer_ticker":"AZYO","issuer_name_source":null,"issuer_url":"/issuer/0001377832","owner_cik":null,"owner_name":"Birchview Fund LLC; Strobeck Matthew; Birchview Capital, LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9061.0,"shares_display":"9,061","price_per_share":3.7939,"price_display":"3.79","price_state":"stated","total_value":34376.5279,"total_display":"34,376.53","shares_owned_after":1511184.0,"shares_owned_after_display":"1,511,184","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-08","filed_date":"2023-02-13","scope":"insider"},{"id":8118484,"accession":"0001104659-23-019991","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001104659-23-019991","line_url":"/filing/0001104659-23-019991#line-5","is_derivative":false,"issuer_cik":"0001377832","issuer_name":"AZIYO BIOLOGICS, INC.","issuer_ticker":"AZYO","issuer_name_source":null,"issuer_url":"/issuer/0001377832","owner_cik":null,"owner_name":"Birchview Fund LLC; Strobeck Matthew; Birchview Capital, LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":3.7853,"price_display":"3.79","price_state":"stated","total_value":15141.2,"total_display":"15,141.20","shares_owned_after":1515184.0,"shares_owned_after_display":"1,515,184","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-08","filed_date":"2023-02-13","scope":"insider"},{"id":8118480,"accession":"0001104659-23-019991","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-23-019991","line_url":"/filing/0001104659-23-019991#line-4","is_derivative":false,"issuer_cik":"0001377832","issuer_name":"AZIYO BIOLOGICS, INC.","issuer_ticker":"AZYO","issuer_name_source":null,"issuer_url":"/issuer/0001377832","owner_cik":null,"owner_name":"Birchview Fund LLC; Strobeck Matthew; Birchview Capital, LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":34000.0,"shares_display":"34,000","price_per_share":3.58,"price_display":"3.58","price_state":"stated","total_value":121720.0,"total_display":"121,720.00","shares_owned_after":1502123.0,"shares_owned_after_display":"1,502,123","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-07","filed_date":"2023-02-13","scope":"insider"},{"id":8118478,"accession":"0001104659-23-019991","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-23-019991","line_url":"/filing/0001104659-23-019991#line-3","is_derivative":false,"issuer_cik":"0001377832","issuer_name":"AZIYO BIOLOGICS, INC.","issuer_ticker":"AZYO","issuer_name_source":null,"issuer_url":"/issuer/0001377832","owner_cik":null,"owner_name":"Birchview Fund LLC; Strobeck Matthew; Birchview Capital, LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":3.58,"price_display":"3.58","price_state":"stated","total_value":35800.0,"total_display":"35,800.00","shares_owned_after":1468123.0,"shares_owned_after_display":"1,468,123","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-07","filed_date":"2023-02-13","scope":"insider"},{"id":8118475,"accession":"0001104659-23-019991","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-019991","line_url":"/filing/0001104659-23-019991#line-2","is_derivative":false,"issuer_cik":"0001377832","issuer_name":"AZIYO BIOLOGICS, INC.","issuer_ticker":"AZYO","issuer_name_source":null,"issuer_url":"/issuer/0001377832","owner_cik":null,"owner_name":"Birchview Fund LLC; Strobeck Matthew; Birchview Capital, LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":4.75,"price_display":"4.75","price_state":"stated","total_value":190000.0,"total_display":"190,000.00","shares_owned_after":1458123.0,"shares_owned_after_display":"1,458,123","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-01","filed_date":"2023-02-13","scope":"insider"},{"id":8118471,"accession":"0001104659-23-019991","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-019991","line_url":"/filing/0001104659-23-019991#line-1","is_derivative":false,"issuer_cik":"0001377832","issuer_name":"AZIYO BIOLOGICS, INC.","issuer_ticker":"AZYO","issuer_name_source":null,"issuer_url":"/issuer/0001377832","owner_cik":null,"owner_name":"Birchview Fund LLC; Strobeck Matthew; Birchview Capital, LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":5.9604,"price_display":"5.96","price_state":"stated","total_value":1192.08,"total_display":"1,192.08","shares_owned_after":1418123.0,"shares_owned_after_display":"1,418,123","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-11","filed_date":"2023-02-13","scope":"insider"},{"id":8253456,"accession":"0001209191-15-055608","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-055608","line_url":"/filing/0001209191-15-055608#line-1","is_derivative":false,"issuer_cik":"0001121702","issuer_name":"METABOLIX, INC.","issuer_ticker":"MBLX","issuer_name_source":null,"issuer_url":"/issuer/0001121702","owner_cik":null,"owner_name":"Birchview Capital GP, LLC; Birchview Capital, LP; Birchview Fund LLC; Birchview Partners, LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":43700.0,"shares_display":"43,700","price_per_share":3.32,"price_display":"3.32","price_state":"stated","total_value":145084.0,"total_display":"145,084.00","shares_owned_after":710366.0,"shares_owned_after_display":"710,366","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-06-19","filed_date":"2015-06-23","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001708527","name":"ELUTIA INC.","url":"/issuer/0001708527","role":"Ten percent owner, Other","n_filings":3,"first_seen":"2023-02-13","last_seen":"2024-02-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001121702","name":"METABOLIX, INC.","url":"/issuer/0001121702","role":"Director","n_filings":1,"first_seen":"2015-06-23","last_seen":"2015-06-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001618205","retrieved_at":"2026-08-21T22:47:09+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}